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Serum vitamin D is associated 
with improved lung function 
markers but not with prevalence 
of asthma, emphysema, 
and chronic bronchitis
Vijay Ganji*, Asma Al‑obahi, Sumaya Yusuf, Zinab Dookhy & Zumin Shi
Hypovitaminosis D has been linked to several non‑bone diseases. Relation between 
25-hydroxyvitamin D [25(OH)D] and lung function and lung diseases has received little attention 
at the global level. Cross-sectional data from three National Health and Nutrition Examination 
Surveys, 2007–2008, 2009–2010, and 2011–2012 were used to investigate the relationship between 
serum 25(OH)D concentrations and lung function makers [forced vital capacity (FVC) and forced 
expiratory volume in 1 s (FEV1)] and lung diseases (asthma, emphysema, and chronic bronchitis) 
with multivariate regression models (n = 11,983; men, 6,010; women, 5,973). Serum 25(OH)D 
concentrations were directly associated with FVC and FEV1 (P for trend < 0.01). Individuals in the 
4th quartile serum 25(OH)D had significantly higher FVC and FEV1 compared to those in the 1st 
quartile (P < 0.01). When data were stratified based on gender and smoking status, we found similar 
associations between serum 25(OH)D concentrations and lung function markers. There was no 
relation between serum 25(OH)D and prevalence of asthma, chronic bronchitis, and emphysema in 
US adults. Serum 25(OH)D concentration is associated with improved lung function markers but not 
with the prevalence of asthma, emphysema, and chronic bronchitis. controlled studies are needed to 
determine if the vitamin D supplementation improves lung function in adults and in smokers.
Abbreviations
25(OH)D  25-Hydroxyvitamin D
BMI  Body mass index
FVC  Forced vital capacity
FEV1  Forced expiratory volume in 1 s
LC-TMS  Liquid chromatography-tandem mass spectrometry
NCHS  National Center for Health Statistics
NHANES  National Health and Nutrition Examination Survey
OR  Odds ratio
PIR  Poverty income ratio
Vitamin D, a lipophilic nutrient, is obtained from diet and supplements. It can also be synthesized in the skin 
from 7-dehydrocholesterol when exposed to Sun’s UV-B light. 25-dihydroxyvitamin D [25(OH)D] is the major 
circulatory form and a commonly used biomarker of vitamin D  status1 although its use is questioned in studies 
linking 25(OH)D concentration with health  outcomes2. The classical function of vitamin D is to maintain the cal-
cium homeostasis. Recent evidence points a role for vitamin D in non-bone infirmities such as type-2  diabetes3, 
metabolic  syndrome4,5, obesity6, cardiovascular  diseases7, some  cancers8,9,  depression10,11, and infectious  disease12. 
Vitamin D deficiency is a global health  problem13. In the US, the vitamin D deficiency [< 50 nmol/L of 25(OH)
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D] is ~ 40% in  201014. Vitamin D status is affected by skin  pigmentation15, geographical  location16,  season17, body 
 adiposity18, disease  status3–12, exposure to sun  light19,  smoking20, race-ethnicity21, and use of sunblock  loation22.
Asthma is a chronic inflammation of the airways resulting in wheezing sound and shortness of breath, cough, 
and chest pains. There is a growing incidence of asthma  globally23,24. Previous studies on the relationship between 
vitamin D concentrations and asthma yielded equivocal  results25–28. In patients with mild to moderate asthma, 
an inverse relationship was observed between vitamin D concentrations and number of asthma  attacks25–27. A 
meta-analysis of studies from double-blind, randomized, placebo-controlled trials on adults (n = 658) showed 
that vitamin D reduced asthma exacerbation  episodes25. Other studies suggested that vitamin D may be used 
for the treatment and control of asthma  symptoms26,27. In contrast, a meta-analysis of seven studies found that 
vitamin D supplementation did not have an effect on reducing asthma severity or lung  function28.
The relationship between serum vitamin D concentrations and lung function and lung diseases in the US 
national data has not been well investigated. A previous study on the US sample reported a direct relation 
between serum 25(OH)D concentrations and lung function markers and inverse association between 25(OH)
D and prevalence of  asthma29. In this current study, we combined three cycles of National Health and Nutrition 
Examination Survey (NHANES), 2007–2008, 2009–2010, and 2011–2012, into one working database. The rela-
tion between serum 25(OH)D and lung function in smokers is not well understood. Also, we studied the relation 
between serum 25(OH)D concentrations and other lung diseases such as emphysema, and chronic bronchitis 
in US adults. Therefore, the objective of this study was to investigate the relationship between serum 25(OH)D 
concentrations and lung function markers and lung diseases in US adults.
Methods
nHAneS description. The National Center for Health Statistics (NCHS) conducts large, nationally rep-
resentative sample surveys called NHANES on civilian US population, using a stratified, multistage, probability 
sample survey  design. NHANESs were conducted as annual surveys  since 1999. Data are released in 2-year 
cycles for public use. Data on demographic factors, food intake, and health were collected from personal inter-
views at the subjects’ homes. Physical examination and collection of blood and urine samples were performed in 
the Mobile Examination Center (MEC). Minorities such as low-income people, adolescents, ≥ 60 years old peo-
ple, non-Hispanic blacks, and Mexican Americans/Hispanics were oversampled to produce reliable estimates 
for these groups. The description of the survey’s methodologies and analytic guidelines were reported in detail 
 elsewhere30.
Survey description. In this study, we used the  data from NHANES 2007–2008, 2009–2010, and 2011–
2012. These three surveys were combined into one analytic data file, NHANES 2007–2012. In short, NHANES 
2007–2008  was conducted between January 2007  and December 2008  on 9,762  subjects.  NHANES 2009–
2010 was conducted from January 2009 to December 2010 on 10,253 subjects. NHANES 2011–2012 was con-
ducted from January 2011 to December 2012 on 9,338 subjects.
Study sample derivation. Data from ≥ 20  years and older participants from NHANES 2007–
2012 were used in this study. Total participants with measured serum 25(OH)D concentration from the com-
bined NHANES 2007–2012 cycles was 15,390. After the exclusion of pregnant women (n = 110) and subjects 
with missing data for smoking (n = 50), BMI (n = 188), physical activity (n = 50), and spirometry (n = 2,909), the 
final analytic sample was 11,983 subjects (weighted sample size, 163,363,012) (Fig. 1). The sample size for the 
analysis of relation between vitamin D and lung diseases such as asthma, emphysema, and chronic bronchitis 
were 11,972, 11,972, and 11,963, respectively.
Vitamin D measurement. Liquid chromatography-tandem mass spectrometry (LC–TMS) was used to 
measure the serum 25(OH)D concentrations at the National Center of Environmental Health of CDC. LC–TMS 
is a better method because of improved analytical specificity and sensitivity compared to the methods that were 
used in the past. The analytical goals for imprecision and bias were ≤ 10% and ≤ 5%, respectively. Serum 25(OH)
D concentration was defined as the sum of 25(OH)D3 and 25(OH)D2.
Description of spirometry. Spirometry data were available only in NHANES 2007–2008, 2009–2010, and 
2011–2012 cycles. Spirometry was performed as per the recommendations of the American Thoracic Society. 
Participants were not eligible for spirometry if they had painful infections, chest pain, physical problems with 
forceful expiration, history of an aneurysm or a detached retina, history of a collapsed lung or exposure to Mico-
bacterium tuberculosis, heart disease, and hemoptysis. Subjects who were on supplemental oxygen were also not 
eligible for spirometry. Participants who had a history of congenital heart disease, hypertension, major arryth-
mia, or recently used the short-acting inhaled β2-agonist and participants who were pregnant or breastfeeding 
were excluded from spirometry. Two lung function markers were selected for the current analysis. These were 
forced vital capacity (FVC) and forced expiratory volume in 1  s (FEV1). Age-, gender-, and race-ethnicity-
specific percent predicted values of FEV1 and FVC were calculated using the normal equations for spirometric 
parameters of the general US population.
Description of confounding variables. Gender, age, race-ethnicity, BMI, poverty-income ratio (PIR), 
season of the survey, use of vitamin D supplements, alcohol intake, smoking, and sedentary activity were used 
as confounding variables. Age and BMI were used as continuous variables. Race-ethnicity was self- identified by 
the participants as non-Hispanic white, non-Hispanic black, Mexican American/Hispanic, and others. Smoking 
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was defined as having blood cotinine concentrations > 1 ng/ml. PIR was calculated by dividing the total family 
income and the family’s poverty threshold. PIR was categorized into three groups, i.e., < 1.0 (low income), 1.0–
2.5 (middle income), and ≥ 2.5 (higher income). Participants without any data for PIR were placed into the “not 
reported” category. Vitamin D supplement use was identified by the participant’s answer to the question “Did 
you take supplements in the past 30 days?”. Information about alcohol drinking was collected by asking “Have 
you had at least 12 alcohol drinks/one year?” The responses were divided into three categories: yes, no, and not 
reported. Sedentary activity is the time usually spent on sitting or reclining (at work, at home, or at school) on 
a typical day. This also included time spent sitting at a desk, sitting with friends, traveling in a car, bus, or train, 
reading, watching television, or using a computer. This did not include time spent sleeping.
Description of asthma, chronic bronchitis, and emphysema. The medical condition of the partici-
pants was self-reported by answering several questions during the personal interview. Participants who answered 
“yes” to the following five questions were considered having asthma: “Has a doctor or other health professional 
ever told you that you have asthma?”, “Do you still have asthma?”, “During the past 12 months, have you had 
an episode of asthma or an asthma attack?”, “During the past 12 months, have you had to visit an emergency 
room or urgent care center because of asthma?”, and “During the past three months, have you taken medication 
prescribed by a doctor or other health professionals for asthma?”. For chronic bronchitis, the participants who 
answered “yes” to the following two questions were considered having chronic bronchitis “Has a doctor or other 
health professional ever told you that you had chronic bronchitis?” and “Do you still have chronic bronchitis?”. 
Regarding the emphysema, the participants who answered “yes” to the following question were considered as 
having emphysema “Has a doctor or other health professional ever told you that you had emphysema?”.
Statistical analysis. Data analysis was performed with STATA software (STATA, Version 16, College Sta-
tion, TX, USA). To produce statistically reliable estimates, a 6-year sample weights were used taking the complex 
survey design into account as per NCHS guidelines. The variance was estimated with the Taylor Linearization 
method. The sample weights and variance estimation methods were described in detail in the NHANES Analytic 
 Guidelines30. Serum 25(OH)D concentrations were stratified into quartiles. The proportion of subjects with lung 
function diseases (asthma, emphysema, and bronchitis) across the quartiles of serum 25(OH)D was compared 
using the χ2 test. The association between prevalence of lung function diseases and serum 25(OH)D concentra-
Total eligible participants with serum 25-
hydroxyvitamin D from the combined data, 
NHANES 2007-2012 (n=15390)
Remaining participants (n=151180)
Missing BMI (n=188)
Remaining participants (n=14892)
Final analytic sample (n=11983)
Missing spirometry (n=2909)
Remaining participants (n=151130)
Remaining participants (n=149142)
<7 year smoking (n=50)
Missing physical activity (n=50)
Pregnant women (n=110)
Figure 1.  STROBE flow chart-sample selection criteria for the association between serum 25-hydroxyvitamin 
D concentration and lung function.
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tion was analyzed with univariate and multivariable logistic regression analysis. Multivariable-adjusted odds 
ratios (OR) and 95% CI were derived for the presence of lung function diseases for each serum 25(OH)D con-
centration quartile category after adjusting the analysis for gender, age, race-ethnicity, sedentary activity, PIR, 
serum cotinine (smoking), alcohol intake, vitamin D supplements intake, season of examination, and BMI. ORs 
for the likelihood of having lung function disease across the quartiles of serum 25(OH)D concentration were 
compared with Bonferroni correction for multiple comparison.
Unadjusted and adjusted means for FVC and FEV1 across the serum 25(OH)D quartiles were generated 
using multivariable regression models. Multivariate models were adjusted for gender, age, race-ethnicity, sed-
entary activity, PIR, serum cotinine, alcohol intake, vitamin D supplements intake, season of examination, and 
BMI. Interactions between serum 25(OH)D and confounding variables were determined and these interaction 
terms were included in the analysis. Because interactions between serum 25(OH)D concentrations and sex and 
smoking status were significant, we performed a separate subgroup analysis for the association between serum 
25(OH)D and FVC and FEV1 by smoking status and gender. Pairwise comparisons between the means of FVC 
and FEV1 across the four quartiles of serum 25(OH)D were performed with Bonferroni correction after test-
ing the hypothesis with Wald F-test. A P-value of ≤ 0.05 was considered statistically significant in all analyses.
ethical approval and consent to participate. All NHANES study protocols were approved by the Eth-
ics Review Committee of NCHS of CDC and all subjects written consented before participation. The reasech was 
conducted in accordance with all the relevant guidelines and regulations.
Results
Subject characteristics of the study population. The characteristics of study participants are shown 
in Table 1. From the combined three cycles of NHANES 2007–2012, a total of 11,983 participants (men, 6,010; 
women, 5,973) ≥ 20 years old, who had serum 25(OH)D concentrations measured were included in the current 
analysis. Gender, age, race-ethnicity, smoking status, alcohol intake, season of examination, BMI, vitamin D 
supplement intake, sedentary activity, and PIR were significantly related to the serum 25(OH)D concentrations. 
It was observed that the higher the age, the higher the serum 25(OH)D concentrations (P < 0.001). Subjects with 
high serum 25(OH)D were more likely to be non-Hispanic white (70%) compared to non-Hispanic black (9%) 
and Mexican American/Hispanic (7%). Among smokers, the highest proportion of subjects were in the lowest 
serum 25(OH)D quartile category (37%). On the other hand, among non-smokers, the highest proportion of 
subjects were in the highest 25(OH)D quartile category (73%). Individuals with low BMI had higher serum 
25(OH)D than those with high BMI. Among non-supplement users, a higher proportion of subjects were in the 
lowest serum 25(OH)D quartile (86%) whereas, among supplement users, a higher proportion of subjects were 
in the highest serum 25(OHD) quartile category.
Serum 25(OH)D and markers of lung function. The association between serum 25(OH)D concentra-
tions and the markers of lung function in US adults is described in Table 2. In the multivariate-adjusted models, 
serum 25(OH)D concentrations were significantly, directly associated with lung function markers, i.e., FVC 
and FEV1 (P for trend < 0.001). Furthermore, individuals in the 4th quartile serum 25(OH)D had significantly 
higher FVC and FEV1 compared to those in the 1st quartile serum 25(OH)D concentration (P < 0.001).
Association between serum 25(OH)D concentrations and FVC and FEV1 by smoking status and sex in US 
adults is presented in Table 3. Similarly, in this subgroup analysis, serum 25(OH)D concentrations were sig-
nificantly, directly associated with the markers of lung function in both smokers and non-smokers and in both 
men and women.
Serum 25(OH)D concentrations and asthma, emphysema, and chronic bronchitis. The asso-
ciation between serum 25(OH)D and prevalence of asthma, emphysema, and chronic bronchitis in US adults is 
described in Table 4. Across the serum 25(OH)D concentration quartiles, the prevalence of asthma, emphysema, 
and chronic bronchitis ranged from 13% to 16%, 0.9% to 1.7%, and 4.5% to 5.4%, respectively. No significant 
relationship was observed between serum 25(OH)D concentrations and the prevalence of asthma, emphysema, 
and chronic bronchitis in both unadjusted and multivariate-adjusted analysis.
Discussion
In this study, we investigated the relationship between serum 25(OH)D concentrations and lung function mark-
ers and a few selected lung diseases such as asthma, emphysema, and chronic bronchitis. We found that serum 
25(OH)D concentrations are directly associated with lung function markers. This is the first study to investi-
gate the association between 25(OH)D concentrations and lung function markers and lung diseases (asthma, 
emphysema, and chronic bronchitis) on the US population using the nationally representative data from three 
cycles of NHANES 2007–2012. Also, we are first to report that in both smokers and non-smokers, vitamin D 
concentrations are directly associated with lung function markers in US adults.
In this study, serum 25(OH)D concentrations are directly associated with FCV and FEV1. Also in smokers, 
we observed a similar relationship with lung function markers. Similar to our findings, a meta-analysis on 27 
studies suggested that serum 25(OH)D concentration was directly associated with lung function in asthma 
 patients31,32. Another study conducted on 2,607 adolescents aged 15 years found that serum 25(OH)D concen-
trations were directly associated with FVC and  FEV1. This association was stronger for FVC than  FEV133. Also 
in COPD patients, a similar association was  found34.
In contrast to our findings, other studies found a negative association between vitamin D concentrations 
and lung function. In a randomized controlled trial on 442 adults (aged 50–84 years old), the subjects received a 
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Table 1.  Subject characteristics of study population (n = 11,983): National Health and Nutrition Examination 
Surveys 2007–2012 [mean ± SD or n (%)].
Serum 25(OH)D quartiles
P-valueQ1 (n = 2,995) Q2 (n = 2,996) Q3 (n = 2,996) Q4 (n = 2,996)
Serum 25(OH)D, nmol/L 32 ± 8 53 ± 5 69 ± 5 97 ± 19  < 0.001
Age, years 44 ± 16 45 ± 16 48 ± 16 51 ± 16  < 0.001
Sex  < 0.001
Men, n 1,410 (47%) 1646 (55%) 1625 (54%) 1,329 (44%)
Women, n 1585 (53%) 1,350 (45%) 1,371 (46%) 1667 (56%)
Race-ethnicity  < 0.001
Non-Hispanic white, n 541 (18%) 1,022 (34%) 1563 (52%) 2099 (70%)
N-Hispanic black, n 1,250 (42%) 600 (20%) 377 (13%) 271 (9%)
Mexican American/Hispanic, n 579 (19%) 662 (22%) 455 (15%) 202 (7%)
Others, n 625 (21%) 712 (24%) 601 (20%) 424 (14%)
Smoking status  < 0.001
Non-smoker, n 1903 (64%) 2089 (70%) 2,146 (72%) 2,194 (73%)
Smoker, n 1,092 (37%) 907 (30%) 850 (28%) 802 (27%)
Alcohol consumption  < 0.001
No, n 455 (15%) 490 (16%) 482 (16%) 440 (15%)
Yes, n 1897 (63%) 1923 (64%) 2028 (68%) 2091 (70%)
Not reported, n 643 (22%) 583 (20%) 486 (16%) 465 (15%)
Season of examination  < 0.001
Winter, n 1826 (61%) 1507 (50%) 1,232 (41%) 964 (32%)
Summer, n 1,169 (39%) 1,489 (50%) 1764 (59%) 2032 (68%)
BMI, kg/m 31 ± 8 30 ± 7 29 ± 6 27 ± 6  < 0.001
Supplement use  < 0.001
No, n 2,579 (86%) 2,236 (75%) 1815 (61%) 1,275 (43%)
Yes, n 416 (14%) 760 (25%) 1,181 (39%) 1721 (57%)
Sedentary activity  < 0.001
 < 3 h, n 971 (32%) 1,093 (37%) 1,029 (34%) 963 (32%)
3–6 h, n 971 (32%) 992 (33%) 1,054 (35%) 1,130 (38%)
 > 6 h, n 1,053 (35%) 911 (30%) 913 (31%) 903 (30%)
Poverty income ratio  < 0.001
 < 1.30, n 1,024 (37%) 943 (35%) 818 (30%) 704 (25%)
1.3–3.5, n 1,068 (39%) 1,019 (37%) 982 (36%) 930 (33%)
 > 3.5, n 650 (24%) 767 (28%) 960 (35%) 1,166 (42%)
Table 2.  Association between serum 25(OH)D concentrations and markers of lung function in US adults 
(n = 11,983): National Health and Nutrition Examination Surveys 2007–2012 (mean ± SE). Means not sharing 
common superscripts are significantly different from each other within the row. Multivatiate analysis was 
adjusted for gender, age, race-ethnicity, sedentary activity, PIR, smoking status, alcohol intake, vitamin D 
supplements intake, season of examination, and BMI.
Serum 25(OH)D quartiles
P-valueQ1 (n = 2,995 ) Q2 (n = 2,996) Q3 (n = 2,996) Q4 (n = 2,996)
FVC, mL
Unadjusted 3,000 ± 20a 3,300 ± 120b 3,310 ± 30b 3,180 ± 30b 0.005
Multivariate-adjusted 3,110 ± 20a 3,200 ± 180b 3,240 ± 20b, c 3,260 ± 20c  < 0.001
FEV1, mL
Unadjusted 3,800 ± 30a 4,180 ± 130b 4,260 ± 30b 4,150 ± 30c  < 0.001
Multivariate-adjusted 4,010 ± 20a 4,090 ± 190b 4,140 ± 20b 4,190 ± 20b  < 0.001
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high-dose of vitamin D supplementation on a monthly basis for 1.1 years. There was no significant improvement 
in lung function although serum 25(OH)D concentrations were improved to > 50 nmol/L. In a subgroup analysis, 
they found that lung function markers (FEV1 and FEV z-score) were improved with vitamin D supplementation 
in ever smokers, in particular those with vitamin D  deficiency35. A cross-sectional study with 1551 men and 
1,391 women did not confirm a positive association between serum 25(OH)D concentrations and lung function 
after controlling for several confounding variables. In COPD patients, a weak relationship was observed between 
serum vitamin D and FEV1/FVC36. This is more likely due to less sample  size37.
Vitamin D has an anti-inflammatory effect that can be modified by exposure to cigarette  smoke38. Exposure 
to cigarette smoking and environmental tobacco smoke were associated with decreased 25(OH)D concentration 
in the  blood39. In a longitudinal cohort study on white men (≥ 20 years old), vitamin D deficiency in relation to 
Table 3.  Association between serum 25(OH)D concentrations and markers of lung function by sex and 
smoking status in US adults: National Health and Nutrition Examination Surveys 2007–2012 (mean ± SE). 
Means not sharing common superscripts are significantly different from each other within the row. Analysis 
was adjusted for gender (only for smoking status model), age, race-ethnicity, sedentary activity, PIR, smoking 
(only for gender model), alcohol intake, vitamin D supplements intake, season of examination, and BMI. 
P-values are significance for interactions between serum 25(OH)D and smoking status or gender.
Serum 25(OH)D quartiles
P-valueQ1 (n = 2,995) Q2 (n = 2,996) Q3 (n = 2,996) Q4 (n = 2,996)
FVC, mL
Smoking status 0.04
 Non-smoker 4,010 ± 20a 4,080 ± 170b 4,140 ± 20b,c 4,210 ± 20c
 Smoker 4,050 ± 30a 4,140 ± 120a,b 4,190 ± 40b 4,150 ± 30a,b
Gender  < 0.001
 Men 4,620 ± 40a 4,770 ± 140a,b 4,850 ± 30b,c 4,960 ± 30c
 Women 3,430 ± 20a 3,460 ± 170a,b 3,460 ± 20a,b 3,460 ± 20b
FEV1, mLe
Smoking status 0.002
 Non-smoker 3,130 ± 20a 3,210 ± 150b 3,280 ± 10b,c 3,320 ± 20c,d
 Smoker 3,080 ± 30a 3,190 ± 110b 3,170 ± 30a,b 3,130 ± 30a,b
Gender 0.009
 Men 3,550 ± 30a 3,700 ± 120b 3,760 ± 20b 3,800 ± 30b
 Women 2,690 ± 20a 2,720 ± 140a,b 2,740 ± 20a,b 2,750 ± 20b,c
Table 4.  Relationship between serum 25(OH)D concentrations and prevalence of asthma, emphysema, and 
chronic bronchitis in US adults: National Health and Nutrition Examination Surveys 2007–2012 [odds ratio 
(95% confidence intervals)].
Serum 25(OH)D quartiles
P-valueQ1 Q2 Q3 Q4
Asthma
n
Cases
2,994
446
2,994
399
2,991
385
2,993
403
Prevalence, % 16.0 14.6 13.2 13.4 0.18
Unadjusted OR (95% CI) 1.23 (0.98–1.55) 1.10 (0.86–1.42) 0.98 (0.79–1.22) 1.0 0.09
Multivariable-adjusted OR (95% CI) 1.19 (0.95–1.51) 1.13 (0.87–1.46) 1.01 (0.80–1.28) 1.0 0.14
Emphysema
n
Cases
2,993
39
2,993
29
2,991
34
2,995
54
Prevalence, % 1.7 0.9 1.3 1.4 0.19
Unadjusted OR (95% CI) 1.19 (0.76–1.88) 0.62 (0.36–1.06) 0.95 (0.58–1.54) 1.0 0.99
Multivariable-adjusted OR (95% CI) 1.11 (0.66–1.87) 0.69 (0.36–1.31) 0.60 (0.36–0.99) 1.0 0.89
Chronic bronchitis
N 2,993 2,991 2,989 2,990
Cases 147 115 142 176
Prevalence, % 5.4 4.5 4.9 5.4 0.58
Unadjusted OR (95% CI) 0.99 (0.71–1.37) 0.82 (0.57–1.17) 0.89 (0.61–1.31) 1.0 0.67
Multivariable-adjusted OR (95% CI) 1.06 (0.71–1.57) 0.98 (0.64–1.49) 0.95 (0.65–1.39) 1.0 0.84
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lung function was examined. In this cohort, no association was found between vitamin D deficiency and lung 
function. In a meta-analysis study, vitamin D did not improve lung function decline in subjects with chronic 
obstructive pulmonary  disease40 .Similar to our results, a study conducted on Chinese found that current smok-
ers had lower vitamin D compared to never smokers, and that relation showed a dose–response pattern. Longer 
duration after quitting smoking was correlated to a higher concentration of (25OH)D than the current smok-
ers (P = 0.04)41. This suggests that vitamin D may have a protective effect on lungs against the damage caused 
by smoking, due to its anti-inflammatory  properties38. In the same cohort, investigators found that vitamin D 
induces the production of antioxidants. This may be beneficial to counteract the effects of oxidative stress caused 
by cigarette smoking. It was found that cigarette smoke decreases the production of the active form of vitamin 
D and affects the expression of vitamin D receptors. Additionally, subjects with vitamin D deficiency with many 
years of smoking had greater lung function  decline38.
In our study, the association between serum 25(OH)D and the prevalence of asthma, emphysema, and chronic 
bronchitis was not statistically significant in both unadjusted and multivariate-adjusted models. However, there 
was a trend toward decrease in the prevalence of asthma as the serum 25(OH)D concentrations increase. Stud-
ies relating vitamin D with asthma has yielded equivocal results. A cross-sectional study based on NHANES 
data found no association between low concentration of serum 25(OH)D and  asthma42. Further, a recent study 
reported no effect of vitamin D supplementation in pregnant women on the prevalence of asthma and recurrent 
wheeze in their  offspring43. A randomized control trial that was done in Saudi adults (n = 1,070) found that the 
association between 25(OH)D concentration and self-reported asthma was not statistically significant in age, 
gender, and BMI adjusted model. The study also found that the percentage of participants with vitamin D defi-
ciency was slightly higher in people with asthma compared to the control  group44. On the other hand, a study 
found an association between serum 25(OH)D and incidence of asthma. The risk of asthma was significantly 
increased with each 25 nmol/L reduction of serum 25(OH)D45. Some studies showed a relationship between 
serum 25(OH)D concentration and asthmatic exacerbation. Vitamin D deficient patients tend to have an increase 
in the frequency of asthma exacerbation and vitamin D supplementation was shown to be effective in reducing 
asthma  exacerbation27,46,47. Limited evidence from randomized controlled studies suggested that in current and 
former smokers supplementation of vitamin D improved lung function and reduced the risk of  asthma48.The 
discrepancy between our study and other studies may be due to sample size and the confounding variables used 
in the multivariate adjusted analysis. Although serum 25(OH)D concentrations are associated with improved 
lung function markers, it may not have stronger effect to make an impact on the lung disease prevalence.
Due to the cross-sectional nature of this study, the cause and effect relationship is not possible. The disease 
diagnosis was self-reported by participants, so the diagnosis of lung diseases may have been under reported. 
Because this study was based on nationally representative sample survey, results can be applied to US population 
at large. In conclusion, serum 25(OH)D was directly associated with lung function markers (FVC and FEV1) in 
US adults. Also, in a separate analysis, a similar association was confirmed between serum 25(OH)D concentra-
tion and lung function markers in smokers and non-smokers and in men and women. However, serum 25(OH)D 
was not significantly associated with the prevalence of asthma, emphysema, and chronic bronchitis. Adequately 
powered, randomized controlled studies are needed to examine if vitamin D supplementation would improve 
lung function markers in general population and specifically in smokers with compromised lung function.
Data availability
All the data supporting the findings within the article and its supplementary files will be available from the cor-
responding author upon request (V.G).
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